BDBM50062796 3-{(S)-4-[2-(4-Carbamimidoyl-benzoylamino)-acetyl]-3-carboxymethyl-2-oxo-piperazin-1-yl}-propionic acid::CHEMBL344506

SMILES NC(=N)c1ccc(cc1)C(=O)NCC(=O)N1CCN(CCC(O)=O)C(=O)[C@@H]1CC(O)=O

InChI Key InChIKey=QYULEGDJRZOHHV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50062796   

TargetIntegrin alpha-IIb/beta-3(Human)
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50062796(3-{(S)-4-[2-(4-Carbamimidoyl-benzoylamino)-acetyl]...)
Affinity DataIC50: 63nMAssay Description:Ability to inhibit binding of biotin-labeled human fibrinogen to immobilized fibrinogen receptor purified from human erythroleukemia (HEL) cells.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Takeda Chemical Industries

Curated by ChEMBL
LigandPNGBDBM50062796(3-{(S)-4-[2-(4-Carbamimidoyl-benzoylamino)-acetyl]...)
Affinity DataIC50: 3.00E+4nMAssay Description:Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of human platelets by 50% in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed